Diabetic Retinopathy Screening Varies Across Minority Groups

This article originally appeared here.
Share this content:
Diabetic Retinopathy Screening Varies Across Minority Groups
Diabetic Retinopathy Screening Varies Across Minority Groups

WEDNESDAY, Jan. 6, 2016 (HealthDay News) -- For patients with diabetes, diabetic retinopathy (DR) screening varies for different minority groups, according to research published online Dec. 30 in Diabetes Care.

Yang Lu, Ph.D., from Los Angeles Biomedical Research Institute in St. Torrance, Calif., and colleagues examined perceived barriers to DR screening in vulnerable populations using survey data collected from 101 patients with diabetes, including 71 Hispanics and 27 African-Americans.

The researchers found that most patients were aware of DR as a potential complication of diabetes, and more than 75 percent reported that a physician had recommended DR screening. However, only 55 percent reported screening in the previous year. African-American patients were screened 50 percent less often than Hispanic patients in the previous year (30.4 versus 62.7 percent; P < 0.01); this was in spite of reporting similar total number of barriers to screening (1.6 each; P = 0.99), similar awareness that diabetes may lead to DR (100 versus 90 percent; P = 0.09), and similar likelihood of receiving a physician screening recommendation (78 versus 77 percent; P = 0.54).

"Our findings of a large discrepancy in DR screening rates among safety-net minority communities may have important implications for consequent risk of blindness," the authors write. "Different approaches to encourage DR screening may be necessary in different minority populations."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »